Results 181 to 190 of about 29,602,681 (295)

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Allocation for Exploratory Development: Modifications in the TORQUE Model

open access: yes
Operations Research ...
Service, Allan L. (Creatorcre)
core  

A new case of <i>Tropheryma whipplei</i> infective endocarditis. [PDF]

open access: yesOxf Med Case Reports
Randrianarisoa RMF   +4 more
europepmc   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

The Alternating Queuing Process with Setup Times

open access: yes
Operations Research ...
Mevert, Peter (Creatorcre)
core  

A new case of <i>Echinococcus ortleppi</i> infection diagnosed by next-generation sequencing in China. [PDF]

open access: yesFront Cell Infect Microbiol
Jia X   +6 more
europepmc   +1 more source

Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression

open access: yesACS Omega, 2018
Ravi Patel   +4 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Administrative Computer Programs for General Mangement Games

open access: yes
Operations Research ...
Braasch, John M. (Creatorcre)
core  

Home - About - Disclaimer - Privacy